These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 17522380)

  • 1. Cathepsin cysteine proteases in cardiovascular disease.
    Lutgens SP; Cleutjens KB; Daemen MJ; Heeneman S
    FASEB J; 2007 Oct; 21(12):3029-41. PubMed ID: 17522380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases.
    Wu H; Du Q; Dai Q; Ge J; Cheng X
    J Atheroscler Thromb; 2018 Feb; 25(2):111-123. PubMed ID: 28978867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications.
    Cheng XW; Huang Z; Kuzuya M; Okumura K; Murohara T
    Hypertension; 2011 Dec; 58(6):978-86. PubMed ID: 21986502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do cathepsins play a role in abdominal aortic aneurysm pathogenesis?
    Sukhova GK; Shi GP
    Ann N Y Acad Sci; 2006 Nov; 1085():161-9. PubMed ID: 17182932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin S expression is up-regulated following balloon angioplasty in the hypercholesterolemic rabbit.
    Burns-Kurtis CL; Olzinski AR; Needle S; Fox JH; Capper EA; Kelly FM; McQueney MS; Romanic AM
    Cardiovasc Res; 2004 Jun; 62(3):610-20. PubMed ID: 15158154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms.
    Aoki T; Kataoka H; Ishibashi R; Nozaki K; Hashimoto N
    Stroke; 2008 Sep; 39(9):2603-10. PubMed ID: 18635848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laminar shear stress inhibits cathepsin L activity in endothelial cells.
    Platt MO; Ankeny RF; Jo H
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1784-90. PubMed ID: 16709945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal cysteine proteases in atherosclerosis.
    Liu J; Sukhova GK; Sun JS; Xu WH; Libby P; Shi GP
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1359-66. PubMed ID: 15178558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of elastolytic cysteine proteases, cathepsins S and K, in the neointima of balloon-injured rat carotid arteries.
    Cheng XW; Kuzuya M; Sasaki T; Arakawa K; Kanda S; Sumi D; Koike T; Maeda K; Tamaya-Mori N; Shi GP; Saito N; Iguchi A
    Am J Pathol; 2004 Jan; 164(1):243-51. PubMed ID: 14695337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis.
    de Nooijer R; Bot I; von der Thüsen JH; Leeuwenburgh MA; Overkleeft HS; Kraaijeveld AO; Dorland R; van Santbrink PJ; van Heiningen SH; Westra MM; Kovanen PT; Jukema JW; van der Wall EE; van Berkel TJ; Shi GP; Biessen EA
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):188-94. PubMed ID: 19095996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cathepsin family and their role in colorectal cancer.
    Kuester D; Lippert H; Roessner A; Krueger S
    Pathol Res Pract; 2008; 204(7):491-500. PubMed ID: 18573619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rd1 Mouse retina shows an imbalance in the activity of cysteine protease cathepsins and their endogenous inhibitor cystatin C.
    Ahuja S; Ahuja-Jensen P; Johnson LE; Caffé AR; Abrahamson M; Ekström PA; van Veen T
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1089-96. PubMed ID: 18326735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics.
    Yasuda Y; Kaleta J; Brömme D
    Adv Drug Deliv Rev; 2005 May; 57(7):973-93. PubMed ID: 15876399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene profiling of cathepsin K deficiency in atherogenesis: profibrotic but lipogenic.
    Lutgens SP; Kisters N; Lutgens E; van Haaften RI; Evelo CT; de Winther MP; Saftig P; Daemen MJ; Heeneman S; Cleutjens KB
    J Pathol; 2006 Nov; 210(3):334-43. PubMed ID: 16972305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
    Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
    Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin S inhibitors as novel immunomodulators.
    Thurmond RL; Sun S; Karlsson L; Edwards JP
    Curr Opin Investig Drugs; 2005 May; 6(5):473-82. PubMed ID: 15912960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis.
    Pozgan U; Caglic D; Rozman B; Nagase H; Turk V; Turk B
    Biol Chem; 2010 May; 391(5):571-9. PubMed ID: 20180636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials.
    Liu CL; Guo J; Zhang X; Sukhova GK; Libby P; Shi GP
    Nat Rev Cardiol; 2018 Jun; 15(6):351-370. PubMed ID: 29679024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsins and cystatin C in atherosclerosis and obesity.
    Lafarge JC; Naour N; Clément K; Guerre-Millo M
    Biochimie; 2010 Nov; 92(11):1580-6. PubMed ID: 20417681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
    Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
    Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.